comparemela.com

Latest Breaking News On - Barinthus biotherapeutics - Page 6 : comparemela.com

ADRs End Higher, Aesthetic Medical International Holdings Group Ltd. Climbs 35.5%

ADRs End Higher, Aesthetic Medical International Holdings Group Ltd. Climbs 35.5%
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

China
New-york
United-states
American
Akso-health-group
Dow-jones-company-inc
Barinthus-biotherapeutics
China-aesthetic-medical-international-holdings-group-ltd
Moatable-inc
Emeren-group-ltd
Uk-biodexa-pharmaceuticals

ADRs End Higher, Aesthetic Medical International Holdings Group Ltd. Climbs 35.5%

This article was automatically generated by Dow Jones Newswires using technology from Automated Insights. International stocks trading in New York closed higher on Wednesday. The S&P/BNY. -April 03, 2024 at 05:12 pm EDT - MarketScreener

New-york
United-states
China
American
China-aesthetic-medical-international-holdings-group-ltd
Akso-health-group
Uk-biodexa-pharmaceuticals
Emeren-group-ltd
Barinthus-biotherapeutics
Moatable-inc
Dow-jones-newswires

Redx Pharma to Quit London Stock Exchange's AIM, Citing Low Liquidity

Redx Pharma to Quit London Stock Exchange's AIM, Citing Low Liquidity
bloomberg.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bloomberg.com Daily Mail and Mail on Sunday newspapers.

London
City-of
United-kingdom
New-york
United-states
Barinthus-biotherapeutics
Zura-bio
London-stock-exchange
Redx-pharma-plc

Barinthus Biotherapeutics (NASDAQ:BRNS) PT Lowered to $8.00 at HC Wainwright

Barinthus Biotherapeutics (NASDAQ:BRNS – Free Report) had its price objective cut by HC Wainwright from $15.00 to $8.00 in a research report released on Thursday, Benzinga reports. They currently have a buy rating on the stock. Separately, William Blair reaffirmed an outperform rating on shares of Barinthus Biotherapeutics in a research report on Monday, January […]

Barinthus-biotherapeutics
William-blair
Free-report
Get-free-report
Nasdaq-brns
Skbrns
Medical
Lower-price-target
Hc-wainwright

Barinthus Biotherapeutics plc (NASDAQ:BRNS) Short Interest Update

Barinthus Biotherapeutics plc (NASDAQ:BRNS – Get Free Report) was the recipient of a significant drop in short interest during the month of February. As of February 15th, there was short interest totalling 14,100 shares, a drop of 55.8% from the January 31st total of 31,900 shares. Based on an average trading volume of 12,000 shares, […]

Barinthus-biotherapeutics
William-blair
Nasdaq
Get-free-report
Nasdaq-brns
Skbrns
Medical
Stocks
Options
Put
Call

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.